ArticleFrontiers in cell and developmental biology2026
Identification of common genes associated with diabetic nephropathy and diabetic retinopathy.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is a common basis of the diabetic nephropathy (DN) and diabetic retinopathy (DR), but the common genes of DN and DR were unclear. Methods: In this study, DN-related and DR-related transcriptome data GSE185011 was extracted. Firstly, the differentially expressed genes 1 (DEGs1) between DN and normal control (HC) samples, and DEGs2 between DR and HC samples were screened by "limma". Then, the common genes of DN and DR were obtained by intersecting the DEGs1 and DEGs2. Next, the enrichment analyses of DEGs1 and DEGs2 were conducted by "ClusterProfiler", and the enrichment analysis of common genes was conducted by "Metascape". Moreover, the diagnostic genes were screened out by least absolute shrinkage and selection operator (LASSO) analysis, and the gene set enrichment analysis (GSEA) of diagnostic genes was performed. Furthermore, the immune cell infiltration analysis was used to further study the differences of disease mechanisms. In addition, the TF-mRNA-miRNA regulatory networks were constructed to reveal the potential regulation of diagnostic genes at the molecular level. Results: A totals of 206 common genes were obtained by intersecting the 526 DEGs1 and 1,059 DEGs2. Then, 6 diagnostic genes (METTL27, NMNAT2, TTC25, GAS6, ATP4A and ZNF223) of DN and 4 diagnostic genes (MCOLN3, C17orf77, ENPP3 and ATP4A) of DR were screened out. Notably, the proportion of central memeory CD4 T cells was significantly decreased in DN groups, and activated B cells was significantly increased in DR groups. Furthermore, the 493 TF-6mRNA-183miRNA regulatory network of DN and 111 TF-4mRNA-33miRNA regulatory network of DR were constructed, among them, hsa-mir-101-3p was the common miRNA for ZNF223, NMNAT2 and TTC25, and EGR1 was the key TF which could regulate ATP4A, GAS6, METTL27, NMNAT2 and TTC25 at the same time. Conclusion: This study revealed the potential molecular mechanisms of diagnostic genes in DN and DR, which could provide novel insights for the clinical diagnosis and treatment of DN and DR.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.